Skip to main content
Top

Drugs

Issue 15/2023

Content (10 Articles)

Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification

Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney

Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Simona Lattanzi, Eugen Trinka, Emilio Russo, Cinzia Del Giovane, Sara Matricardi, Stefano Meletti, Pasquale Striano, Payam Tabaee Damavandi, Mauro Silvestrini, Francesco Brigo

Befotertinib: First Approval

  • NSCLC
  • AdisInsight Report

Hannah A. Blair

Talquetamab: First Approval

Susan J. Keam

Correction to: Ritlecitinib: First Approval

  • Open Access
  • Correction

Hannah A. Blair

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images